1. A phase II study of outpatient first-line paclitaxel, carboplatin, and bevacizumab for advanced-stage epithelial ovarian, peritoneal, and fallopian tube cancer. Issue 4 (1st July 2007) Authors: Micha, J. P.; Goldstein, B. H.; Rettenmaier, M. A.; Genesen, M.; Graham, C.; Bader, K.; Lopez, K. L.; Nickle, M.; Brown, J. V. Journal: International journal of gynecological cancer Issue: Volume 17:Issue 4(2007) Page Start: 771 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗